World journal of microbiology & biotechnology

How CRISPR shifts from immune defense to controlling infection in Salmonella

Updated

Abstract

The Type I-E CRISPR/Cas system in Salmonella enterica may function as a regulatory interface influencing bacterial pathogenesis.

  • The system is thought to be integrated into regulatory networks that control pathogenicity islands, biofilm formation, and responses to oxidative stress.
  • CRISPR components such as Cascade, Cas3, and Cas6 may deviate from traditional immunity functions, allowing for DNA binding without lethal cleavage.
  • This binding is associated with transcriptional modulation via steric hindrance, which could act as a natural interference mechanism.
  • Global regulators like H-NS and LeuO may coordinate this system in response to environmental changes, such as fluctuations in pH.
  • These findings suggest potential for new therapeutic strategies, including anti-CRISPR therapeutics.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

0 of 4
authors report competing interests
4 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free